Mammaly vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (40 vs 41)
Mammaly logo

Mammaly

EmergingPet Care

General

Cologne Germany premium dog supplement market leader with 350K+ European customers; €14M Iris Ventures/Five Seasons Series A Sep 2023 with Tractive data partnership for measurable supplement efficacy competing with Zesty Paws for European pet health.

AI VisibilityBeta
Overall Score
C40
Category Rank
#465 of 1158
AI Consensus
77%
Trend
up
Per Platform
ChatGPT
43
Perplexity
51
Gemini
51

About

Mammaly is a Cologne, Germany-based premium dog supplement company — backed with €14 million in Series A funding in September 2023 co-led by Iris Ventures (consumer specialist) and Five Seasons Ventures (food tech) with participation from pet industry veteran Attila Balogh — providing 350,000+ dog owners across Europe with veterinarian-developed functional supplement treats in 25+ recipes addressing digestion, joint care, dental hygiene, skin health, and relaxation. Germany's market leader for premium dog supplements, Mammaly differentiates from traditional supplement formats (pills, powders) through palatability-optimized functional treat formats that dogs consume willingly — combining clinical effectiveness with taste appeal that drives owner adherence to supplement regimens. In 2025, Mammaly announced a strategic partnership with Tractive (world's leading smart pet tracker) to measure supplement effectiveness through objective GPS and vital signs data at scale. Founded in 2020 in Berlin by Stanislav Nazarenus and Alexander Thelen. Certified B Corporation.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

40
Overall Score
41
#465
Category Rank
#777
77
AI Consensus
50
up
Trend
up
43
ChatGPT
35
51
Perplexity
49
51
Gemini
33
48
Claude
51
44
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.